Title:
ヒト抗セマフォリン４Ｄ抗体
Document Type and Number:
Japanese Patent JP2023075271
Kind Code:
A
Abstract:
【課題】セマフォリン４Ｄ（ＳＥＭＡ４Ｄ）の病理に関連する疾患（たとえば、自己免疫疾患、炎症性疾患、がん、神経炎症性疾患、及び神経変性疾患）を治療するための組成物及び方法を提供する。【解決手段】重鎖可変領域（ＶＨ）及び軽鎖可変領域（ＶＬ）を含む、セマフォリン４Ｄ（ＳＥＭＡ４Ｄ）に特異的に結合する抗体またはその抗原結合断片、ならびに該抗体またはその抗原結合断片と、キャリアとを含む、医薬組成物を提供する。【選択図】図１
Inventors:
Smith Ernest S.
Cornelison Angelica
Scrivens Maria G.M.
paris mark
Sauderer Maurice
Cornelison Angelica
Scrivens Maria G.M.
paris mark
Sauderer Maurice
Application Number:
JP2023039438A
Publication Date:
May 30, 2023
Filing Date:
March 14, 2023
Export Citation:
Assignee:
Baxinex Incorporated
International Classes:
C12N15/13; A61K39/395; A61P9/10; A61P19/02; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P29/00; A61P35/00; A61P37/02; C07K16/28; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/08
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Kousuke Umemura
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Maki Shioda
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Kousuke Umemura
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Maki Shioda
Kazuya Kawamoto
Previous Patent: Prebiotics for treating disorders associated with disturbed composition or function of the gut micro...
Next Patent: cancer treatment
Next Patent: cancer treatment